Skip to Content
Merck
  • Establishment of new highly insulin-sensitive cell lines and screening of compounds to facilitate glucose consumption.

Establishment of new highly insulin-sensitive cell lines and screening of compounds to facilitate glucose consumption.

Journal of pharmacological sciences (2008-11-15)
Kenji Hayata, Katsuichi Sakano, Shigeyuki Nishinaka
ABSTRACT

To obtain compounds that promote glucose uptake in muscle cells, the novel cell lines A31-IS derived from Balb/c 3T3 A31 and C2C12-IS from mouse myoblast C2C12 were established. In both cell lines, glucose consumption was induced by insulin and suppressed by the addition of Akt-activating kinase inhibitor. The A31-IS cells highly express the insulin receptor beta chains, Glut4, and uncoupling protein-3, as compared to the parent Balb/c 3T3 A31 cells, and C2C12-IS cells highly express the insulin receptor beta chain as compared to its parent cell line. Using A31-IS cells, we screened our library compounds and obtained three compounds, DF-4394, DF-4451, and DG-5451. These compounds dose-dependently promoted glucose consumption in A31-IS cells and facilitated [3H]-2-deoxyglucose uptake in differentiated C2C12-IS cells. The compounds that we obtained from the library screening will be good candidates for improving insulin resistance in muscle cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5-(2-Benzothiazolyl)-3-ethyl-2-[2-(methylphenylamino)ethenyl]-1-phenyl-1H-benzimidazolium iodide, ≥98% (HPLC)
Sigma-Aldrich
2-Bromohexadecanoic acid, ~97%